Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))

Byung Sik Cho; Zhihong Zeng; Hong Mu; Zhiqiang Wang; Sergej Konoplev; Teresa McQueen; Marina Protopopova; Jorge Cortes; Joseph R. Marszalek; Sheng Bin Peng; Wencai Ma; R. Eric Davis; Donald E. Thornton; Michael Andreeff; Marina Konopleva

doi:10.1182/blood-2015-07-657387

Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))

Byung Sik Cho
, Zhihong Zeng
, Hong Mu
, Zhiqiang Wang
, Sergej Konoplev
, Teresa McQueen
, Marina Protopopova
, Jorge Cortes
, Joseph R. Marszalek
, Sheng Bin Peng
, Wencai Ma
, R. Eric Davis
, Donald E. Thornton
, Michael Andreeff
, Marina Konopleva

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1049
Number of pages	1
Journal	Blood
Volume	126
Issue number	8
DOIs	https://doi.org/10.1182/blood-2015-07-657387
State	Published - Aug 20 2015
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2015-07-657387

Cite this

Cho, B. S., Zeng, Z., Mu, H., Wang, Z., Konoplev, S., McQueen, T., Protopopova, M., Cortes, J., Marszalek, J. R., Peng, S. B., Ma, W., Davis, R. E., Thornton, D. E., Andreeff, M., & Konopleva, M. (2015). Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232)). Blood, 126(8), 1049. https://doi.org/10.1182/blood-2015-07-657387

Cho, BS, Zeng, Z, Mu, H, Wang, Z, Konoplev, S, McQueen, T, Protopopova, M, Cortes, J, Marszalek, JR, Peng, SB, Ma, W, Davis, RE, Thornton, DE, Andreeff, M & Konopleva, M 2015, 'Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))', Blood, vol. 126, no. 8, pp. 1049. https://doi.org/10.1182/blood-2015-07-657387

@article{c00ce7ffe0174dacb219ac19d4a9394f,

title = "Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))",

author = "Cho, \{Byung Sik\} and Zhihong Zeng and Hong Mu and Zhiqiang Wang and Sergej Konoplev and Teresa McQueen and Marina Protopopova and Jorge Cortes and Marszalek, \{Joseph R.\} and Peng, \{Sheng Bin\} and Wencai Ma and Davis, \{R. Eric\} and Thornton, \{Donald E.\} and Michael Andreeff and Marina Konopleva",

year = "2015",

month = aug,

day = "20",

doi = "10.1182/blood-2015-07-657387",

language = "English (US)",

volume = "126",

pages = "1049",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "8",

}

TY - JOUR

T1 - Errata

T2 - Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))

AU - Cho, Byung Sik

AU - Zeng, Zhihong

AU - Mu, Hong

AU - Wang, Zhiqiang

AU - Konoplev, Sergej

AU - McQueen, Teresa

AU - Protopopova, Marina

AU - Cortes, Jorge

AU - Marszalek, Joseph R.

AU - Peng, Sheng Bin

AU - Ma, Wencai

AU - Davis, R. Eric

AU - Thornton, Donald E.

AU - Andreeff, Michael

AU - Konopleva, Marina

PY - 2015/8/20

Y1 - 2015/8/20

UR - https://www.scopus.com/pages/publications/84940069096

UR - https://www.scopus.com/pages/publications/84940069096#tab=citedBy

U2 - 10.1182/blood-2015-07-657387

DO - 10.1182/blood-2015-07-657387

M3 - Comment/debate

AN - SCOPUS:84940069096

SN - 0006-4971

VL - 126

SP - 1049

JO - Blood

JF - Blood

IS - 8

ER -

Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this